Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

October 10, 2015 3:12 PM ET

Life Sciences Tools and Services

Company Overview of RainDance Technologies, Inc.

Company Overview

RainDance Technologies, Inc. develops genomic tools for non-invasive liquid biopsy applications for the research, early detection, and treatment of cancer, and other inherited and infectious diseases. It offers RainDrop, a digital polymerase chain reaction platform that generates picoliter-sized droplets for multiplex detection of HIV, DNA, or RNA; and consumables, such as source chips and sense chips, and oil surfactants. The company provides ThunderStorm, an automated next-generation sequencing (NGS) content enrichment solution that enable researchers to process various samples per day and generate quality data; ThunderBolts, a NGS panel for profiling important cancer mutations; ThunderBol...

749 Middlesex Turnpike

Billerica, MA 01821

United States

Founded in 2004

104 Employees





Key Executives for RainDance Technologies, Inc.

Chief Executive Officer, President and Director
Age: 38
Co-Founder and Chief Technology Officer
Age: 46
Chief Financial Officer
Age: 61
Compensation as of Fiscal Year 2015.

RainDance Technologies, Inc. Key Developments

RainDance Technologies, Inc. Appoints Kathy Ordonez as the Chairman of the Board of Directors

RainDance Technologies, Inc. announced the appointment of Kathy Ordoez as chairman of its board of directors. Ms. Ordoez brings more than 30 years of experience in the life sciences and diagnostics industries, and has served on the board of directors since 2014, and as the chair of the board’s science and innovation committee. As senior vice president at Quest Diagnostics, Kathy Ordoez was responsible for leading the company's businesses in diagnostic products, insurer services, clinical trials and healthcare information technology products and also led research and development. Ordoez was previously the chief executive officer at Celera and a founder of Celera Diagnostics.

Pacific Biosciences of California, Inc. and RainDance Technologies, Inc. Partner to Co-Develop and Commercialize Novel Solution For de novo Whole Genome Assembly

Pacific Biosciences of California, Inc. and RainDance Technologies, Inc. announced their entry into a co-development and co-marketing agreement to commercialize novel solutions for de novo whole genome assembly. These solutions will combine the power of RainDance's proprietary digital droplet technology and single-molecule barcoding capabilities with Pacific Biosciences' proprietary long-range DNA amplification technology to provide sample preparation upstream of PacBio's long-read sequencing system. This combination could provide a method to generate millions of long, single-molecule barcoded DNA fragments, averaging 10-30 kilobases that originated from much longer (100 kilobase) fragments. Combining this fragmentation and labeling scheme with a sequence context-unbiased amplification method for long DNA fragments, PacBio sequencing could provide de novo, haplotype-phased assembly of complex genomes. This would be possible even in genomic regions containing complex repeats or PCR-challenged sequences that limit performance of synthetic long-read approaches based upon short-read sequencing technologies. Furthermore, this approach will be designed to work with low DNA input as little as 1 ng to address scarce or difficult-to-procure samples.

RainDance Technologies, Inc. Announces Global Availability of the Thunderbolts Myeloid Panel

RainDance Technologies, Inc. announced global availability of the ThunderBolts Myeloid Panel, a next-generation sequencing (NGS) research assay designed to rapidly detect and cost-effectively analyze genetic mutations associated with AML (Acute Myeloid Leukemia), MDS (Myelodysplastic Syndromes), MPN (Myeloproliferative Neoplasms) and other myeloid cancer research. The research assay was developed with the RainDanceHemOnc Consortium, a select group of hematologic oncology experts drawn from prominent academic and cancer research centers in the U.S. and Europe. HemOnc Consortium members will present the latest performance data from the new panel during the American Association for Cancer Research (AACR) Annual Meeting in Philadelphia on April 18-22, 2015. The ThunderBolts Myeloid Panel is a pre-validated NGS assay for researching mutations and hotspots in 49 important genes implicated in the causation, prognosis and recurrence of certain blood and bone marrow cancers. The panel features NGS breakthroughs in low sample input (10 ng), high sequencing coverage (100 percent), uniformity (greater than 95 percent), and time-to-result (2.5 days). Scientists are using the ThunderBolts Myeloid Panel to profile mutations that can then be independently validated and monitored with the ultra-sensitive RainDrop® Digital PCR System, all based on a unified and single droplet technology platform. The HemOnc Consortium is continuing to work with RainDance to conduct research into a proprietary digital PCR portfolio of cell-free mutation assays to study and monitor the status of important genes in blood-based cancer progression and relapse.

Similar Private Companies By Industry

Company Name Region
Cromos Pharma,LLC United States
Toxikon Corp. United States
Kestrel Consultants, Inc. United States
Regulatory Compliance Associates Inc. United States
Prevalere Life Sciences, Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact RainDance Technologies, Inc., please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at